Home Blog Page 11

CarsRadiation.org Launches to Share Verified Data on EMF in Vehicles

Staff Writer
-
0
CarsRadiation.org Launches to Share Verified Data on EMF in Vehicles

A new information platform, CarsRadiation.org, is now available for drivers, buyers, engineers, health professionals, and policymakers looking for reliable data on electromagnetic field (EMF) exposure inside electric and hybrid vehicles. The site presents verified reports, structured summaries of peer-reviewed publications, and interpretation of exposure levels based on standards such as ICNIRP, WHO, IEC 62764, and China NCAP.

Content is prepared in collaboration with engineers and public-health researchers. All material is reviewed for accuracy by professionals in system architecture, electromagnetic compliance, and health science. The objective is to convert technical readings into clear, usable information for both technical and non-technical audiences.

“With millions of people now spending hours each week in electrified vehicles, it’s critical that the public has access to clear, science-based information about in-car radiation, its sources, and potential health effects.” – Shaul Shulman, Contributing Editor at CarsRadiation.org

“With millions of people now spending hours each week in electrified vehicles, it’s critical that the public has access to clear, science-based information about in-car radiation, its sources, and potential health effects.” said Shaul Shulman, Co-founder and Co-CEO of SafeFields Technologies, and Contributing Editor at CarsRadiation.org. “We aim to bridge the gap between industry data and public knowledge.”

Core content areas of the site include:

  • Magnetic field level measurements in leading EV and hybrid models
  • Summaries of published studies on biological effects of long-term exposure
  • Side-by-side breakdowns of global guidelines and safety thresholds
  • Technical recommendations for reducing EMF exposure in vehicles
  • Regular tracking of regulatory activity and manufacturer disclosures

CarsRadiation.org is a structured resource focused on electromagnetic exposure from electric and hybrid vehicle systems. It offers validated analysis, standard references, and exposure-mitigation guidance. The platform is intended for anyone seeking to understand health-related implications of low-frequency magnetic fields in modern vehicles.

Mercury Insurance Unveils This Year’s Most Affordable New Trucks and SUVs to Insure

Staff Writer
-
0
Mercury Insurance Unveils This Year’s Most Affordable New Trucks and SUVs to Insure

The truck and sport utility vehicle segments continue to remain among the most sought-after among American consumers. That’s why Mercury Insurance (NYSE: MCY), a leading auto insurer in California, has compiled a list of the most affordable new trucks and SUVs to insure for 2025, announced today. This list was created with the goal of helping consumers find a capable vehicle that will help them maximize insurance savings amid rising insurance costs nationwide.

Factors contributing to insurance costs include claims on similar vehicles, costs to repair and vehicle safety records. Mercury’s research and development team examined vehicles that are available at car dealerships today to compile this list.

“Choosing a vehicle with utility doesn’t have to break the bank, as any of these vehicles will help keep the cumulative cost of ownership down, which is something we have always emphasized at Mercury.”

This is the 10th year that Mercury has published this list, which includes 2025 and 2026 model-year vehicles.

“We understand that in the current climate, consumers are looking to save money on auto insurance, but we also know that many in the new-car market are looking to add a truck or SUV to their driveway,” said Chong Gao, Director of Product Management R&D for Mercury Insurance. “The good news is that there’s a lot of variety in this year’s list for consumers with different budgets and lifestyles, from compact SUVs to larger midsize ones that can handle family duty.”

The top 10 list for trucks, beginning with the most affordable make and model to insure is:

  • Chevrolet Colorado LT
  • Chevrolet Silverado C3500
  • Ford Maverick/Ford Ranger
  • Hyundai Santa Cruz SE
  • Toyota Tundra CrewMax
  • Ford F150
  • Toyota Tacoma
  • Ford F350 Super Duty
  • Dodge 1500/RAM Truck 1500
  • GMC Canyon

The top 10 list for SUVs, also beginning with the most affordable make and model to insure is:

  • Hyundai Sante Fe
  • Honda Pilot
  • Chevrolet Blazer
  • Kia Sportage
  • Honda Passport
  • Ford Escape
  • Kia Soul
  • Honda HR-V
  • Honda CR-V
  • Kia Sorento

“Choosing a vehicle with utility doesn’t have to break the bank, as any of these vehicles will help keep the cumulative cost of ownership down, which is something we have always emphasized at Mercury,” said Gao.

About Mercury Insurance

Mercury Insurance (NYSE: MCY) is a multiple-line insurance carrier predominantly offering personal auto, homeowners, renters and commercial insurance through a network of independent agents in Arizona, California, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas and Virginia, as well as auto insurance in Florida. Mercury writes other lines of insurance in various states, including commercial, business owners and business auto, landlord, home-sharing, ride-hailing and mechanical protection insurance.

Since 1962, Mercury has provided customers with tremendous value for their insurance dollar by pairing ultra-competitive rates with excellent customer service, through more than 4,200 employees and a network of more than 6,340 independent agents in 11 states. Mercury has earned an “A” rating from A.M. Best, as well as “Best Auto Insurance Company” designations from Forbes and Insure.com. For more information visit http://www.MercuryInsurance.com or follow the company on X, Instagram or Facebook.

Hemmings Data Shows First-Generation Ford Bronco Auction Sales Averaging Over 14% Above Reserve as Iconic SUV Turns 60

Staff Writer
-
0
Hemmings Data Shows First-Generation Ford Bronco Auction Sales Averaging Over 14% Above Reserve as Iconic SUV Turns 60

With values outpacing vintage Jeep, Land Rover, and Chevrolet rivals, the first-gen Bronco remains the most collectible model

BENNINGTON, VT – (August 12, 2025) — As the Ford Bronco celebrates its 60th anniversary this summer, Hemmings, the world’s largest online collector car marketplace, is spotlighting the first-generation Bronco (1966–1977), the most collectible era in the SUV’s history and the design inspiration for today’s modern Bronco.

Over the past five years, first-gen Broncos sold through Hemmings Auctions have averaged 14.2% above reserve, with standout years commanding even higher premiums. The 1966 models averaged 20.2% over reserve and 1989 models achieved 24% over reserve. Current listings on Hemmings.com range from $5,500 driver-quality builds to fully restored custom examples approaching $300,000.

Bronco Values and Market Position in 2025
According to Hemmings’ Marketplace Editor, Terry Shea, in today’s collector market, first-gen Broncos command an average value of $82,000, significantly ahead of vintage competitors such as the 1969–1972 Chevrolet K5 Blazer ($68,000), the 1971–1975 Land Rover Series III ($23,000), and the 1972–1978 Jeep CJ5 ($19,000). Among the highest-valued years:

  • 1974 Ford Bronco: $98,000
  • 1971 Ford Bronco: $93,000
  • 1969 Ford Bronco: $91,000

“The first generation is the heart and soul of the Bronco story,” said Shea. “It bridges eras and audiences, has deep nostalgic appeal, and continues to deliver a strong return for collectors, especially as original or lightly restored examples become harder to find.”

A Look Back at Bronco’s First Generation
Debuting in August 1965 for the 1966 model year, the Ford Bronco entered a market dominated by Jeep and Land Rover, offering an “all-purpose vehicle” in three body styles: Wagon, Sport Utility (pickup), and Roadster. Nearly 90% of first-gen production was the hardtop Wagon with the pickup accounting for 8% of sales and the Roadster just over 2%.

Powered by a variety of inline-six and small-block V8 engines, including the 170-cu.in. OHV six and the 302-cu.in. OHV V8, the Bronco combined rugged durability with surprisingly refined road manners, thanks to coil springs at all four corners.

The Baja Bronco: First-Gen’s Crown Jewel
From 1971 to 1975, legendary builder Bill Stroppe created the Baja Bronco to celebrate back-to-back Baja 1000 wins with Parnelli Jones. Finished in distinctive red, white, and blue paint with a satin black hood, heavy-duty suspension, fender flares, and desert-ready equipment, and with only 450–650 Baja Broncos produced, it makes the SUV the most collectible first-gen variant. Hemmings currently features a pristine example for sale: 1973 Ford Baja Bronco Listing at just under $175,000.

First-Generation Ford Bronco Production Snapshot (1966–1977):

  • Highest year: 1974 with 25,824 units
  • Lowest year: 1975 with 13,125 units

Six decades after its debut, the first-generation Bronco continues to stand as a symbol of American adventure and a benchmark in the collector SUV market.

Browse every Ford Bronco currently listed on Hemmings online marketplace here.

About Hemmings  

Founded in 1954, Hemmings is the world’s largest online collector car marketplace. For more than 70 years, we have grown and uplifted the collector car community because we’ve been part of it since the start. Through our frictionless marketplace, quality entertainment, and professional service, we help all willing drivers buy, sell, and live the collector car lifestyle. Hemmings Motor Club extends this mission by bringing enthusiasts together through exclusive benefits, curated driving experiences, and deeper community connections for those who live to drive. More information, services, and content are available at https://www.hemmings.com/. Stay connected with Hemmings on Facebook, Instagram, and YouTube, and search tens of thousands of vehicle listings from the palm of your hand with the Hemmings App.  

Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials

Staff Writer
-
0
Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials

MMS, a global, data-focused clinical research organization (CRO), announced today that it has been chosen by Friends of Cancer Research (Friends), a leading nonprofit dedicated to accelerating innovation in cancer research, to support the development of practical decision frameworks to inform the interpretation of interim overall survival (OS) data in oncology clinical trials.

The collaboration addresses a longstanding challenge in cancer drug development: how to assess long-term treatment benefit when OS data remain immature. In many oncology studies, developers use endpoints such as progression-free survival (PFS) and objective response rate (ORR) as an initial indicator of treatment efficacy. However, evaluating OS data at the same interim point can complicate the assessment of long-term benefit or harm. To provide clarity, Friends has convened a consortium of stakeholders to develop and evaluate different modeling scenarios, including crossover effects and delayed treatment benefits.

Friends selected MMS to lead simulation and modeling efforts for this project based on both its simulation platform, KerusCloud®, and its deep bench of regulatory and statistical experts. The MMS platform enables realistic modeling of oncology endpoints and allows stakeholders to explore different scenarios and decision thresholds, providing a clear view of the potential risks and benefits associated with acting on immature data in oncology clinical trials, and supporting more informed decisions earlier in the trial process.

“As timely access to innovative cancer therapies remains a key factor for patients, this initiative represents an important step toward optimal acceleration,” said Jeff Allen, PhD, President and CEO, Friends of Cancer Research. “At Friends, we work with key stakeholders to generate the evidence necessary to understand a problem, and develop data-driven policy solutions to address and overcome that problem; all while keeping the patients front of mind. We are excited to partner with MMS along with the consortium who bring a combination of statistical depth, real-world understanding of oncology trial design, and powerful simulation tools to help tackle these challenges.”

Improving Oncology Clinical Trials with the Right Technology and the Right Stakeholders

“Friends of Cancer Research has long been a catalyst for forward-thinking collaboration in oncology, and we are grateful they have trusted MMS to support this vital initiative,” said Uma Sharma, PhD, CEO at MMS. “Having supported several key oncology approvals, we are uniquely positioned to help model the right questions and deliver practical frameworks that will shape future regulatory guidance and support better decision-making across the field.”

“By combining our regulatory insight with advanced simulation capabilities, we are helping develop practical tools and decision frameworks that give developers greater confidence to act on early data, and ultimately improve access for patients,” added Aiden Flynn, Sr. VP Strategic Statistical Consulting at MMS.

The collaboration is expected to result in practical guidance and a simulation toolbox that can be shared broadly across the oncology community, helping stakeholders better anticipate the implications of interim OS data on regulatory decisions. By equipping researchers with a practical, scientifically robust toolkit, this program promotes a consistent and transparent approach to evaluating early survival signals, supports timely decision-making, and fosters continued innovation in cancer drug development. To learn about the Interim OS Project, visit https://friendsofcancerresearch.org/interim-os, and learn more about KerusCloud at https://mmsholdings.com/ai-technology/keruscloud-clinical-trial-simulation/.

About Friends of Cancer Research

Friends of Cancer Research (Friends) powers advances in science and policy that speed life-saving treatments to patients. Friends aims to accelerate cutting edge cancer care that both extends and improves quality of life for patients.  To accomplish this, we leverage groundbreaking collaborations, generate scientific evidence, and integrate patient input to shape public policy. For more information, please visit https://friendsofcancerresearch.org.

About MMS

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, a 19-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating. For more information, visit www.mmsholdings.com.

Trialt Wins Gold Stevie® Award for Company of the Year as a CRO in the Pharmaceutical Industry at 2025 International Business Awards

Staff Writer
-
0
Trialt Wins Gold Stevie® Award for Company of the Year as a CRO in the Pharmaceutical Industry at 2025 International Business Awards

Trialt, a global clinical research organization (CRO) specializing in biostatistics, statistical programming, data management, and medical writing, has been awarded a Gold Stevie® Award for Company of the Year in the pharmaceutical industry in the 22nd Annual International Business Awards®.

The International Business Awards are among the world’s most prestigious honors for business performance and innovation. Organizations across more than 60 nations submitted nominations for this year’s program. Trialt earned the top honor based on consistently high scores from independent judges across multiple categories for its operational excellence and impact across the global life sciences sector.

“This recognition is clear proof of the dedication and expertise of our entire biometrics and medical writing teams,” said Michael Vulikh, CEO of Trialt. “We are proud to support pharmaceutical and biotech sponsors across the world with services, tools, and resourcing that helps move clinical trials forward, and we will continue to work in bringing fresh approaches to the work that motivates us.”

Trialt’s award-winning performance includes its role in scaling biometrics operations for global sponsors, delivering under pressure in complex rescue studies, and helping bring AI-powered innovation to regulatory and market access operations.

Meeting the Moment in a Rapidly Expanding Market

According to the Clinical Research Organization Global Market Report 2025, the CRO market is projected to grow at a compound annual growth rate (CAGR) of 10 percent. Due to this, the pharmaceutical and biotechnology industries are seeing a growing demand for globalized clinical trials, a sharp increase in therapeutic complexity, and the urgent need for specialized expertise.

Vulikh added, “As clinical trial sponsors take on more ambitious drug development programs, they are seeking partners who can scale quickly, deliver with consistency, and fill gaps in specialized areas. This is why Trialt’s FSP resourcing model has been in such high demand recently.”

Trialt’s Functional Service Provider (FSP) model offers sponsors the ability to deploy embedded talent across biostatistics, programming, data management, and medical writing with minimal ramp-up and maximum continuity. Trialt leaders have trained and integrated an extensive amount of statistical programmers through its delivery framework to support large sponsors and CROs meet critical milestones and scale without hiring.

To learn more about Trialt’s services, visit www.trialt.com.

For details on the 2025 International Business Awards, visit www.StevieAwards.com/IBA.

About Trialt

Trialt is the trusted CRO partner for biostatistics, statistical programming, data management, and medical writing. With expert teams across eight countries and deep engineering roots, we deliver tailored solutions designed to move trials forward and produce measurable results. Named “Company of the Year – Pharmaceutical Industry” in the 2025 International Business Awards, sponsors turn to Trialt to scale complex programs, recover at-risk studies, and meet critical timelines with confidence. Learn more at www.trialt.com.

SW North America Presents its New Modular and Automated Mobile Robot Cell for More Efficient Manufacturing and CNC Machining

Staff Writer
-
0
SW North America Presents its New Modular and Automated Mobile Robot Cell for More Efficient Manufacturing and CNC Machining

SW North America, a leading provider of CNC machining centers and automation solutions, announced a new solution for modular automation: the Mobile S-Cell robot cell, a scalable unit that flexibly connects assembly, logistics, and machining stations. It supports manufacturing companies in the automated and efficient machining of a wide variety of components and order volumes, without rigid interlinking or complex integration.

SW’s Mobile S-Cell takes over automated processes such as handling workpieces and operating machining, washing, or assembly stations, thereby replacing manual processes in production.

“The S-Cell is a modular, mobile solution that gives manufacturers freedom to scale automation in a way that’s smarter, faster, and more efficient, and we’re proud to introduce the Mobile S-Cell to the North American market,” said Andrew Rowley, General Sales Manager at SW North America, Inc. “With its combination of high productivity, modular design, flexible application options, and end-to-end connectivity, the self-sufficient Mobile S-Cell fits seamlessly into modern manufacturing environments, especially where product diversity and dynamic production requirements are commonplace.”

Smart automation that moves with you

The S-Cell is mounted on a mobile carrier system and can be moved through the production environment using a driverless transport system (Mobile S-Wagon). The cell docks at the desired station, be it machining, washing, assembly, or a DMC laser station. An integrated robot with a gripping system takes the raw material from upstream storage stations, known as Mobile S-Storages, loads the machining station, and returns the workpieces after completing the process. The Mobile S-Storages are also automatically movable by the Mobile S-Wagon, and the workpieces are fed and removed independently of the cell.

“The flexibility of the S-Cell gives our customers a competitive edge,” said Rowley. “They can start small, scale quickly, and reconfigure as needs evolve while avoiding massive capital investments or rigid infrastructure.”

The patent-pending system supports payloads up to 120kg, or 264.5 lbs, and is compatible with both SW machines and third-party systems. Power and control are delivered by the connected station or through SW’s proprietary automation platform, which coordinates robots, transport systems, and job data.

Another advantage is that the cell only docks at a station temporarily, keeping the station freely accessible at all other times – for cleaning, maintenance or similar tasks. This keeps the system highly available and easy to integrate.

Modular production concept for greater flexibility and scalability

The strengths of the concept lie in its modularity and mobility. Companies can start with just a few modules and expand the system step by step as required. This provides a clear advantage over fixed production lines.

The Mobile S-Cell demonstrates its advantages particularly when component types and quantities change frequently, such as in the automotive industry with engine blocks, oil pans, or bushings. By using several cells in parallel the system runs consistently at high capacity, even with short cycle times of less than 10 minutes. Companies also benefit from the modular concept: they can start with just a few units and expand the system flexibly as needed.

Learn more about SW’s automation and speak to an expert at https://sw-machines.com/us/products/automation/.

About SW North America

SW North America is a subsidiary of Schwäbische Werkzeugmaschinen GmbH, a leading international manufacturer of smart manufacturing solutions. With its North American headquarters in Michigan, SW is the world market leader in multi-spindle CNC machining centers for cutting a variety of materials across the automotive, electromobility, agricultural and construction machinery, medical technology, and aerospace industries.

SW currently has more than 1,700 employees across its global headquarters in Schramberg-Waldmössingen, Germany, and locations in China, France, Hungary, Mexico, Poland, and the United States. The company achieved a group turnover of $535 million in 2022.

Learn more about SW North America at https://sw-machines.com/us/.

Co-Founder of Velesco Pharmaceutical Appointed to Board of Directors at TSRL

Staff Writer
-
0
Co-Founder of Velesco Pharmaceutical Appointed to Board of Directors at TSRL

The Preclinical CRO welcomes biopharma industry veteran Gerry Cox

ANN ARBOR, Mich. (August 6, 2025) — TSRL, Inc., a preclinical CRO specializing in testing services and early-stage development strategies, announced today the appointment of Gerry Cox to its Board of Directors, effective immediately. Cox brings more than 30 years of biopharma leadership experience in pharmaceuticals and life sciences, having held senior executive positions at major industry players including Pfizer, Velesco, and Pace Analytical Life Sciences.

Cox’s extensive background spans finance, operations, and strategic leadership across the life sciences sector, having previously served as Senior Finance Director at Pfizer and more recently Chief Operating Officer and Co-Founder of Velesco.

“We are honored to welcome Gerry to the board, and his appointment represents a strategic step that aligns perfectly with TSRL’s growth goals,” said Elke Lipka, PhD, CEO of TSRL. “His proven track record in building and scaling life sciences organizations aligns with our mission to provide strategic, science-forward support to companies navigating early-stage drug development.”

Based in Boston, Cox’s appointment provides TSRL with enhanced connectivity to the thriving East Coast biotechnology and life sciences ecosystem. This strategic geographic presence complements TSRL’s Ann Arbor headquarters and positions the company to better serve clients and partners across key life sciences corridors. His appointment comes at a pivotal time for TSRL as the company continues to expand its capabilities and deepen its role as a trusted partner to pharma, biotech, academic, and government clients.

“I have long admired TSRL’s scientific approach and its commitment to strong scientific research and preclinical testing,” said Gerry Cox. “TSRL has built an impressive foundation, and I look forward to helping the organization further drive meaningful impact across the drug development lifecycle to become the preclinical CRO of choice.”

TSRL’s board includes leaders from Ash Stevens Inc, the Drug Delivery Foundation, the University of Michigan, and more, guiding the company’s long-term vision and supporting its mission to help sponsors move compounds from discovery to clinical readiness.

Learn more at www.tsrlinc.com.

About TSRL

TSRL, Inc. is a preclinical contract research organization (CRO) specializing in formulation development, bioanalysis, exploratory toxicology, and pharmacokinetic strategies to guide human dosing schedules. Based in Michigan, TSRL supports pharmaceutical, biotechnology, academic, and government partners with a science-first approach that goes beyond standard testing. As a preclinical CRO, TSRL delivers a focused set of services that help research teams move drug candidates forward. Each solution is designed to reduce development risk, generate high-quality data, and support better decision-making earlier in the process. Learn more at www.tsrlinc.com.

McLean Media Named PR Agency of Record for Hemmings, World’s Largest Online Collector Car Marketplace

Staff Writer
-
0
McLean Media Named PR Agency of Record for Hemmings, World’s Largest Online Collector Car Marketplace

DETROIT (July 15, 2025) – McLean Media, a growing Michigan-based public relations agency, today announced that it has been selected as the PR agency of record for Hemmings, the world’s largest online collector car marketplace. The partnership comes at a transformative time for Hemmings as the company embraces its heritage as a full-service provider to passion-fueled, collector car communities while advancing the growing demand for comprehensive products, services, and news that the industry expects from the iconic brand. The agreement between the two companies took effect July 1, 2025.

The collaboration represents a natural alignment between McLean Media’s automotive PR and marketing expertise and Hemmings’ position as the premier destination for collector car enthusiasts. Founded in 1954, Hemmings has evolved from a print publication, Hemmings Motor News, to a digital leader in the collector car space, connecting buyers and sellers of classic, vintage, and specialty vehicles worldwide.

“This partnership is incredibly meaningful to me both professionally and personally,” said Don F. McLean, Founder and President of McLean Media and member of the Hemmings Motor Club. “Hemmings is a brand that I’ve believed in since I first opened its pages in the 1980s, and having the opportunity to help tell their story and support their mission of connecting classic car lovers is truly a dream come true.”

The timing of the partnership coincides with Hemmings’ most significant brand evolution in decades. The company’s Hemmings Auctions and Make Offer Listings, combined with its recent launch of the Hemmings Motor Club, positions Hemmings to better serve the growing collector car market. This occurs through improving knowledge, building a stronger sense of community, and removing traditional barriers (i.e. valuation challenges, secure payment transfer, title verification, and roadside assistance) to buying, selling, and maintaining classic vehicles.

“We’re thrilled to partner with McLean Media as we enter this exciting new chapter,” said Jonathan Shaw, President at Hemmings. “This team’s deep understanding of automotive, combined with their genuine passion for vintage cars, makes them the ideal partner to help us communicate our enhanced value proposition to enthusiasts worldwide. Their authentic connection to our community and proven track record will be invaluable as we push to expand our offerings and reach new audiences.”

McLean Media will provide comprehensive public relations support for the continued growth and market leadership of Hemmings, as well as its tools and services.

McLean added, “The collector car market has experienced significant growth in recent years, with classic vehicles increasingly viewed as alternative investments and passion purchases. The depth of Hemmings and its innovative digital offerings will power us to capitalize on this momentum while maintaining the trust and authenticity that has defined the brand for more than 70 years.”

To learn more about the brand, visit https://www.hemmings.com

About McLean Media
McLean Media is an award-winning strategic communications agency that helps mission-driven leaders grow their visibility and influence. Led by Don F. McLean, MBA, the firm blends public relations, content strategy, and personal brand development to position clients as trusted voices in their industries. McLean Media turns messaging into momentum by helping clients lead conversations, earn trust, and stand out where it counts. 

For more information, visit https://www.linkedin.com/company/mcleanmediaco/. 

About Hemmings

Founded in 1954, Hemmings is the world’s largest online collector car marketplace. For more than 70 years, we have grown and uplifted the collector car community because we’ve been part of it since the start. Through our frictionless marketplace, quality entertainment, and professional service, we help all willing drivers buy, sell, and live the collector car lifestyle. Hemmings Motor Club extends this mission by bringing enthusiasts together through exclusive benefits, curated driving experiences, and deeper community connections for those who live to drive.More information, services, and content are available at Hemmings.com. Stay connected with Hemmings on Facebook, Instagram, and YouTube, and search tens of thousands of vehicle listings from the palm of your hand with the Hemmings App.

Media Contacts

Rachel Slotnick, rachel@mcleanmedia.co, +1-313-595-6549

Mary Beth Halprin, marybeth@mcleanmedia.co, +1-586-365-8149

###

Trialt Names Dr. Yuri Kartashov as Chief R&D Officer to Reinforce Strong Biostatistics and Clinical Data Leadership at the Global CRO

Staff Writer
-
0
Trialt Names Dr. Yuri Kartashov as Chief R&D Officer to Reinforce Strong Biostatistics and Clinical Data Leadership at the Global CRO

Trialt, a leading global contract research organization (CRO) specializing in biostatistics, statistical programming, data management, and medical writing, today announced the appointment of Yuri Kartashov, PhD as its new Chief Research and Development (R&D) Officer. Dr. Kartashov brings more than two decades of experience leading high-performing teams and developing advanced statistical solutions that accelerate clinical trials and regulatory success.

Trialt, a leading global contract research organization (CRO) specializing in biostatistics, statistical programming, data management, and medical writing, today announced the appointment of Yuri Kartashov, PhD as its new Chief Research and Development (R&D) Officer.

“Yuri’s deep expertise in data science, statistical innovation, and cross-functional collaboration is exactly what we need to power our next stage of growth,” said Michael Vulikh, CEO of Trialt. “He understands the critical role of data in driving drug development forward, and he brings a visionary approach that aligns with our mission: to help sponsors navigate complexity, recover at-risk studies, and meet critical timelines with confidence.”

With teams across eight countries and engineering roots that support custom, scalable solutions, Trialt has built a reputation as a trusted partner for sponsors facing fast-moving clinical landscapes. The company’s services include:

  • Biostatistics: Strategic statistical planning and analysis that inform confident, data-driven decisions
  • Statistical Programming: Comprehensive programming solutions supporting all kinds of biometrics deliverables, real-world evidence generation, and trial-related marketing analytics
  • Data Management: End-to-end solutions ensuring data integrity, security, and compliance
  • Medical Writing: Submission-ready documents tailored to global regulatory expectations

Kartashov most recently held dual roles, serving as vice president of data management and analytics at Veranex and as co-founder and R&D advisor at Cliniphai, where he demonstrated a strong track record of leading innovative R&D initiatives across the life sciences and CRO sectors. At Trialt, he will lead the company’s scientific and technical strategy, driving forward data-centric trial execution and ensuring delivery of high-quality, regulatory-ready outcomes.

“This is an extraordinary time to be shaping the future of clinical development,” said Kartashov. “Trialt is uniquely positioned to lead the way in how data is leveraged to improve trial efficiency, rescue high-stakes programs, and support global submissions. I’m proud to join a team that’s committed to excellence, and I look forward to building on its momentum.”

For more information about Trialt and its full-service offerings, visit www.trialt.com.

DRIVESHARE Launches Global Classic Car Events Directory to Connect Enthusiasts Worldwide

Staff Writer
-
0
DRIVESHARE Launches Global Classic Car Events Directory to Connect Enthusiasts Worldwide

DOVER, DELAWARE – JULY 14, 2025  – DRIVESHARE, the premier platform for renting unique and special cars for weddings, events, photo shoots, and experiences, announced today, a comprehensive global directory designed to become the definitive resource for classic car events worldwide. DRIVESHARE Events invites car enthusiasts, clubs, and event organizers to contribute to what aims to be the most complete calendar of classic car activities globally.

The new platform addresses a longstanding challenge in the classic car community: the difficulty of discovering quality events beyond local networks. DRIVESHARE Events welcomes all types of classic car gatherings, from major annual concours shows to intimate morning coffee meetups and niche club gatherings.

The heart of the classic car community lives in its events, where stories are swapped, engines are admired, and lifelong friendships are made, said Kent Mosbech, CEO of DRIVESHARE. “But until now, discovering those moments often relied on luck or word of mouth. With DRIVESHARE Events, we’re putting the full calendar in everyone’s hands, no matter where they are in the world. It’s built by enthusiasts, for enthusiasts, and we can’t wait to see where the road takes us together.”

The platform’s success depends on community participation, with DRIVESHARE inviting enthusiasts who know the scene best to populate the directory. Early submissions are already coming in from locations spanning Geneva to Fort Lauderdale, demonstrating the platform’s global reach.

In addition to event listings, DRIVESHARE Events now includes a dedicated car club directory. Local clubs, from tight-knit marque enthusiast groups to large regional organizations, can list their communities to attract new members and connect with like-minded enthusiasts globally.

DRIVESHARE plans to promote featured events through multiple channels, including newsletters, social media, and blog features. The platform is currently accepting submissions from event organizers and car clubs worldwide, with the goal of creating the most comprehensive classic car event resource available. Organizers can submit their events here. It’s free and open to all.

For more information, visit https://events.driveshare.com/. 

About DRIVESHARE

DRIVESHARE is a peer-to-peer car-sharing community that connects classic and collector car owners with enthusiasts seeking unforgettable driving experiences. Whether it’s for a wedding, photo shoot, special event, or simply the joy of driving a vintage vehicle, DRIVESHARE offers a curated selection of unique cars across the country. The platform emphasizes shared passions, trust, and human connection, ensuring that every rental includes an in-person key handoff and flexible coverage options. For more information, visit DRIVESHARE.com.

1...101112...19Page 11 of 19

About us

Boardroom Buzz is your go-to source for breaking news, insights, and trends shaping today’s business landscape. We deliver sharp, executive-level coverage on leadership moves, industry shifts, and emerging opportunities—helping decision-makers stay informed and ahead of the curve.

Company

The latest

Subscribe

© 2025 McLean Media. All Rights Reserved.